The Pancreatic Cancer Sequencing Team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins received the Team Science Award from the American Association for Cancer Research (AACR) at the AACR's Annual Meeting held in Washington, D.C., on 7th , 2013. This $50,000 award recognizes an outstanding interdisciplinary research team for its innovative and meritorious scientific work that has advanced or will likely advance cancer research, detection, diagnosis, prevention or treatment. The Hopkins team was selected based on its tremendous impact on understanding of the fundamental genetic changes that characterize pancreatic cancer. The interdisciplinary team, led by Ralph H. Hruban, M.D., comprises 20 faculty members from three different institutions: Johns Hopkins University in Baltimore, Md.; Emory University in Atlanta, Ga.; and Memorial Sloan-Kettering Cancer Center in New York, N.Y. Margaret Foti, Ph.D., M.D., chief executive officer of the AACR, said that the team's "research has greatly contributed to our knowledge of pancreatic cancer, which currently has an extremely poor prognosis. They have provided a wonderful example of the innovative scientific discoveries we can expect to find when the efforts of multiple institutions and different biomedical fields collaborate."
Pictured above are:
Row 1 (left to right): David Klimstra, Kenneth Kinzler, Ralph Hruban (team leader), Bert Vogelstein, Nicholas Papadopoulos, Michael Choti, Victor Velculescu
Row 2: (left to right): Christopher Wolfgang, Joseph Herman, Laura Wood Row 3: (left to right): Scott Kern, N. Volkan Adsay, Alison Klein, Christine Iacobuzio-Donahue
Not pictured: Peter Allen, Luis Diaz, James Eshleman, Michael Goggins, Anirban Maitra and Alan Meeker
Pictured above with Katie Couric are Drs. Michael Goggins, Alan Meeker, James Eshleman, and Ralph Hruban.
The Baltimore and Washington D.C. affiliates of PanCAN, the national pancreatic cancer advocacy group, visited the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins on Saturday March 24, 2013. Approximately 50 patients, family members and advocates visited. The morning started with welcoming remarks by Teresa Barth, Marsha Balsinger from PanCAN, and an introduction by Dr. Ralph Hruban from the Hopkins team. The visitors then broke up into eleven small groups for small informal meetings with the doctors, scientists and health care providers at Hopkins. Each group spent 10-15 minutes with a member of the Hopkins team, and then moved to the next team member. Dr. Hruban described it as "speed dating!" Most importantly, the PanCAN visitors got a close-up and personal tour of the labs and the opportunity to meet and chat with a number of the world leaders in pancreatic cancer care and research.
The team members from Hopkins who participated in the event included: